Outcome Health announced the launch of Who Saves Me?, a campaign to bring awareness to the overwhelming percentage of physicians who quietly suffer from burnout and mental health struggles. 

In recognition of World Suicide Prevention Day, FCB Health New York announced the launch of “Disappearing Doctors,” a pro bono initiative advocating for and providing mental health support to physicians in need, in partnership with Sermo, Haymarket Media Group and the National Suicide Prevention Lifeline.

Much more often than not, attempting to talk to friends or family members about their potential drug or alcohol abuse is a sensitive, challenging, and sometimes painful undertaking. It is natural for an individual who is addicted to drugs or alcohol, not to recognize the long-term consequences that cause pain and suffering to more people than just themselves. When seeking to help others overcome their addiction and the constant struggle with substance abuse, sometimes it is through those caring friends or family members that the user can finally find some relief2 by setting boundaries.

A look at some of the more interesting scientific studies recently published, including the COVID-19 lockdown causing increased mental health issues.

Powered by Xconomy, November 2019’s What’s Next in Neuroscience Therapies event brought together scientists, entrepreneurs and biotech executives at the Hyatt Regency San Francisco to discuss their work developing next-generation neuroscience therapies and technologies in areas such as spinal-cord injuries, precision mental health, dementia and Alzheimer’s disease.

Researchers said Evidence is weak for whether medicinal cannabis treatments can relieve mental illnesses such as anxiety, depression and psychosis, and doctors should prescribe them with great caution.

Healthline Media and the National Alliance on Mental Illness announced the winners of the Healthline Stronger Scholarship, which is awarded to four university students around the U.S. for their commitment to academic and professional pursuits in mental health.

Poor sleep may be linked to a greater risk for poor mental health on college campuses, new research suggests.

Allergan Plc’s Vraylar won U.S. regulatory approval to treat depressive episodes of bipolar I disorder, expanding the scope of treatment to a full spectrum of symptoms related to the condition.

Sage Therapeutics shares were up after the company won approval for the postpartum depression treatment Zulresso (brexanalone).